All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
MRNA real return snapshot: after CPI-U inflation, MRNA returned +614.41% over the past year and +546.83% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +697.06% in real purchasing-power return, or +30.12%/yr, and is currently â66.81% below its real total-return high on Aug. 9, 2021.
Data ending Mon Oct. 26, 2026
| Fri 2018-12-07đŹ to Mon 2026-10-26 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+697.06%
+30.12%/yr |
+1.09%/yr
R2=0.001 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07đŹ to Mon 2026-10-26 |
Start
Value |
End
Value |
|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$79,706.44
2026-10-26 |
| YTD | YoY | |
|---|---|---|
| MRNA × | +546.83% | +614.41% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| MRNA × |
â66.81%
on 2026-10-26 from 2021-08-09 peak |
â96.11%
on 2025-11-20 from 2021-08-09 peak |
| Period ending Mon 2026-10-26 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| MRNA × | +614.41% |
+249.92% +87.06%/yr |
+138.38% +33.58%/yr |
â52.97% â14.01%/yr |
— |
| Year | MRNA |
|---|---|
| 2026 (YTD) | +546.83% |
| 2025 | â30.92% |
| 2024 | â59.36% |
| 2023 | â46.43% |
| 2022 | â33.57% |
| 2021 | +127.13% |
| 2020 | +426.92% |
| 2019 | +25.23% |
| 2018 | â17.70% |